retatrutide mechanism of action retatrutide clinical trials 2024 2025 Xia & He Publishing Retatrutide TRIUMPH-4 Results: Are We

# Retatrutide: How to Reconstitute and Take Your First Dose Retatrutide (LY3437943) is a triple agonist it hits GLP-1, GIP, and glucagon receptors simultaneously

Rotate injection sites (belly, thigh, upper arm)

Changes in circulating levels of LDL-C, high-density lipoprotein cholesterol and free fatty acids were not statistically different between various patient groups in the diabetes study [4]

has received honoraria or has been a consultant for Angelini, AbbVie, Boehringer Ingelheim, Lundbeck and Otsuka

The FDA estimates that 10 deaths and 100 hospitalizations may be linked to the use of compounded GLP-1RAs

Its unique mechanism of action targets both GIP and GLP-1 receptors, setting it apart from other peptides that focus on single pathways